Literature DB >> 20236056

Anti-vasopermeability effects of PEDF in retinal-renal disorders.

S Ueda1, S-I Yamagishi, S Okuda.   

Abstract

The vascular system has an important function of supplying tissues with oxygen and nutrients and clearing waste products. Therefore, the microvasculature must be sufficiently permeable to allow the free, bidirectional passage of small molecules and gases and, to a lesser extent, of plasma proteins. It is well recognized that vascular endothelial growth factor (VEGF) can increase vascular permeability, thus playing important roles in variety of disorders, including diabetic retinopathy, nephrotic syndrome, brain edema, acute respiratory distress syndrome, and sepsis-associated hypotension. However, how vascular permeability is controlled by anti-permeable factors is not fully understood. We have recently found that pigment epithelium derived factor (PEDF), a 50 kD glycoprotein, inhibits retinal, renal and brain hyperpermeability by counteracting the biological actions of VEGF. In this review, we discuss about the pathophysiological role of PEDF in vascular permeability, especially focusing on retinal-renal disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20236056     DOI: 10.2174/156652410791065291

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  9 in total

1.  Perivascular-resident macrophage-like melanocytes in the inner ear are essential for the integrity of the intrastrial fluid-blood barrier.

Authors:  Wenjing Zhang; Min Dai; Anders Fridberger; Ahmed Hassan; Jacqueline Degagne; Lingling Neng; Fei Zhang; Wenxuan He; Tianying Ren; Dennis Trune; Manfred Auer; Xiaorui Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-11       Impact factor: 11.205

2.  Targeting therapy of choroidal neovascularization by use of polypeptide- and PEDF-loaded immunoliposomes under ultrasound exposure.

Authors:  Tao Li; Ming Zhang; Yong Han; Hong Zhang; Lingjuan Xu; Yan Xiang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-12-22

3.  Overexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization.

Authors:  Kyoungmin Park; Ji Jin; Yang Hu; Kevin Zhou; Jian-xing Ma
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

4.  Pigment Epithelium-derived Factor secreted by corneal epithelial cells regulates dendritic cell maturation in dry eye disease.

Authors:  Rohan Bir Singh; Tomas Blanco; Sharad K Mittal; Yukako Taketani; Sunil K Chauhan; Yihe Chen; Reza Dana
Journal:  Ocul Surf       Date:  2020-05-06       Impact factor: 5.033

5.  Perivascular macrophage-like melanocyte responsiveness to acoustic trauma--a salient feature of strial barrier associated hearing loss.

Authors:  Fei Zhang; Min Dai; Lingling Neng; Jin Hui Zhang; Zhongwei Zhi; Anders Fridberger; Xiaorui Shi
Journal:  FASEB J       Date:  2013-05-31       Impact factor: 5.191

6.  Potential therapeutic effects of pigment epithelium-derived factor for treatment of diabetic retinopathy.

Authors:  Xiao Liu; Hui-Hui Chen; Li-Wei Zhang
Journal:  Int J Ophthalmol       Date:  2013-04-18       Impact factor: 1.779

7.  Pigment Epithelium-Derived Factor Improves Paracellular Blood-Brain Barrier Integrity in the Normal and Ischemic Mouse Brain.

Authors:  Arina Riabinska; Marietta Zille; Menderes Yusuf Terzi; Ryan Cordell; Melina Nieminen-Kelhä; Jan Klohs; Ana Luisa Piña
Journal:  Cell Mol Neurobiol       Date:  2019-12-20       Impact factor: 5.046

8.  Pigment Epithelium-Derived Factor Enhances the Suppressive Phenotype of Regulatory T Cells in a Murine Model of Dry Eye Disease.

Authors:  Rohan B Singh; Tomas Blanco; Sharad K Mittal; Hamid Alemi; Sunil K Chauhan; Yihe Chen; Reza Dana
Journal:  Am J Pathol       Date:  2021-01-14       Impact factor: 4.307

9.  PEDF regulates vascular permeability by a γ-secretase-mediated pathway.

Authors:  Jun Cai; Lin Wu; Xiaoping Qi; Sergio Li Calzi; Sergio Caballero; Lynn Shaw; Qing Ruan; Maria B Grant; Michael E Boulton
Journal:  PLoS One       Date:  2011-06-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.